Oncology

Glioblastoma Multiforme treatment may extend current one year survival rate.

Drug could eventually also treat prostate cancer.

Drug failed in treatment of solid tumors but shows promise blocking amyloid-beta plaques.

Natural extract found to reduce cell growth in triple negative breast cancer.

Less toxic drug class combined with fasting may kill breast, lung, and colon cancer cells equally well.

Engineered protein improves survival rates in aggressive leukemia.

Crohn's disease specifically carries greater risk for developing cervical cancer.

Donna M. Smith, PharmD, director of clinical affairs at Avella Specialty Pharmacy discusses strategies for the management of new lung cancer treatment options.

Compounds that prevent protein aggregation may lead to therapy for conditions such as cancer and diabetes.

Kyprolis has already been approved for patients who failed at least 2 previous therapies.

Researchers believe drug will lead to ‘new paradigm' in leukemia therapy.

Scalp cooling technology seeks to ensure hair retention in most instances.

Blood test may identify patients who need more intensive chemotherapy.

Teikoku Pharma USA has submitted a New Drug Application to the FDA for the product.

Current smokers and those who quit less than 10 years prior to surgery face twice the risk of disease recurrence.

Genetic changes in tumors linked to immune system response to disease.

Costs have risen 120% in aggregate since 1995.

Formic acid from stinging nettles and ants greatly increases treatment's ability to shut down cancer cells.

Errors in genes may leave tumors susceptible to PARP inhibitors.

Treatment increases immune response with fewer side effects.

Nanoscale treatment could potentially eliminate cancer cells without harming surrounding tissue.

Emerging technology could help patients make better decisions regarding whether to undergo aggressive prostate cancer treatment.

Discovery may lead to new treatment designs.

Risk of sudden onset menopause reduced by adding goserelin to chemotherapy regimen.

Treatment can selectively drop medication at the site of tumors.

Survivors of breast cancer more likely to develop aggressive form of thyroid cancer.

Study finds older patients and minorities less likely to receive treatment.

Study finds depression in African American cancer patients has gone under-recognized.